Genomic landscape of the DHA1 family in the newly emerged pathogen Candida auris and mapping substrate repertoire of the prominent member CauMdr1
暂无分享,去创建一个
R. V. Prasad | A. Lynn | Poonam Vishwakarma | A. Banerjee | Amresh Prakash | Parth Aggarwal | Suman Sharma | Rosy Khatoon | Amandeep Saini
[1] Christina A. Cuomo,et al. In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris , 2021, bioRxiv.
[2] P. Schläpfer,et al. DomainViz: intuitive visualization of consensus domain distributions across groups of proteins , 2021, Nucleic Acids Res..
[3] K. Kuchler,et al. Transcriptome Signatures Predict Phenotypic Variations of Candida auris , 2021, Frontiers in Cellular and Infection Microbiology.
[4] D. Sanglard,et al. Novel ERG11 and TAC1b Mutations Associated with Azole Resistance in Candida auris , 2021, Antimicrobial Agents and Chemotherapy.
[5] A. Chakrabarti,et al. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points , 2021, Journal of medical microbiology.
[6] R. Prasad,et al. Directed Mutational Strategies Reveal Drug Binding and Transport by the MDR Transporters of Candida albicans , 2021, Journal of fungi.
[7] Andrew M. Lynn,et al. ABC-finder: A containerized web server for the identification and topology prediction of ABC proteins , 2020, bioRxiv.
[8] A. Lorenz,et al. What do we know about the biology of the emerging fungal pathogen of humans Candida auris? , 2020, Microbiological research.
[9] Guanghua Huang,et al. Candida auris: Epidemiology, biology, antifungal resistance, and virulence , 2020, PLoS pathogens.
[10] Christina A. Cuomo,et al. Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance , 2020, mBio.
[11] A. Bonifaz,et al. Antifungal Resistance in Candida auris: Molecular Determinants , 2020, Antibiotics.
[12] Christina A. Cuomo,et al. Mutations in TAC1B: a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris , 2020, mBio.
[13] Marie-Franqoise Paul,et al. Saccharomyces cerevisiae , 2020, Catalysis from A to Z.
[14] Christina A. Cuomo,et al. Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses , 2020, mBio.
[15] A. Mondal,et al. Cdr1p highlights the role of the non-hydrolytic ATP-binding site in driving drug translocation in asymmetric ABC pumps. , 2019, Biochimica et biophysica acta. Biomembranes.
[16] R. Prasad,et al. Multidrug transporters of Candida species in clinical azole resistance. , 2019, Fungal genetics and biology : FG & B.
[17] H. Badali,et al. Potential Fifth Clade of Candida auris, Iran, 2018 , 2019, Emerging infectious diseases.
[18] N. Gow,et al. ABC Transporter Genes Show Upregulated Expression in Drug-Resistant Clinical Isolates of Candida auris: A Genome-Wide Characterization of ATP-Binding Cassette (ABC) Transporter Genes , 2019, Front. Microbiol..
[19] Sneha P. Couvillion,et al. Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen , 2019, mSystems.
[20] K. Barker,et al. Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris , 2019, Antimicrobial Agents and Chemotherapy.
[21] Christina A. Cuomo,et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species , 2018, Nature Communications.
[22] R. Prasad,et al. Phylogenetic and conservation analyses of MFS transporters , 2018, 3 Biotech.
[23] H. Gohlke,et al. FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops , 2018, Antimicrobial Agents and Chemotherapy.
[24] A. Borman,et al. Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance , 2018, mSphere.
[25] Sudhir Kumar,et al. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.
[26] A. Chowdhary,et al. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance , 2018, The Journal of antimicrobial chemotherapy.
[27] P. Falson,et al. Molecular Basis of Substrate Polyspecificity of the Candida albicans Mdr1p Multidrug/H+ Antiporter. , 2018, Journal of molecular biology.
[28] Cristina Aurrecoechea,et al. FungiDB: An Integrated Bioinformatic Resource for Fungi and Oomycetes , 2018, Journal of fungi.
[29] R. Prasad,et al. Resistance to antifungal therapies. , 2017, Essays in biochemistry.
[30] A. Borman,et al. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris , 2017, Emerging infectious diseases.
[31] Christina A. Cuomo,et al. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] R. Prasad,et al. MFS transporters of Candida species and their role in clinical drug resistance. , 2016, FEMS yeast research.
[33] Evan W. Floden,et al. PSI/TM-Coffee: a web server for fast and accurate multiple sequence alignments of regular and transmembrane proteins using homology extension on reduced databases , 2016, Nucleic Acids Res..
[34] Miguel C. Teixeira,et al. Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2* , 2015, Molecular & Cellular Proteomics.
[35] R. Prasad,et al. The ABCs of Candida albicans Multidrug Transporter Cdr1 , 2015, Eukaryotic Cell.
[36] P. Dias,et al. Phylogenetic and syntenic analyses of the 12-spanner drug:H(+) antiporter family 1 (DHA1) in pathogenic Candida species: evolution of MDR1 and FLU1 genes. , 2014, Genomics.
[37] Rupinder Kaur,et al. Novel role of a family of major facilitator transporters in biofilm development and virulence of Candida albicans. , 2014, The Biochemical journal.
[38] Miguel C. Teixeira,et al. Candida glabrata Drug:H+ Antiporter CgQdr2 Confers Imidazole Drug Resistance, Being Activated by Transcription Factor CgPdr1 , 2013, Antimicrobial Agents and Chemotherapy.
[39] Rohitash Kumar,et al. Candida albicans Flu1-Mediated Efflux of Salivary Histatin 5 Reduces Its Cytosolic Concentration and Fungicidal Activity , 2013, Antimicrobial Agents and Chemotherapy.
[40] Sean R Eddy,et al. A new generation of homology search tools based on probabilistic inference. , 2009, Genome informatics. International Conference on Genome Informatics.
[41] Miguel C. Teixeira,et al. Drug:H+ antiporters in chemical stress response in yeast. , 2009, Trends in microbiology.
[42] Y. Uehara,et al. Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.
[43] Miguel C. Teixeira,et al. The yeast multidrug transporter Qdr3 (Ybr043c): localization and role as a determinant of resistance to quinidine, barban, cisplatin, and bleomycin. , 2005, Biochemical and biophysical research communications.
[44] D. Sanglard,et al. TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.
[45] Sandra Tenreiro,et al. Saccharomyces cerevisiae Aqr1 Is an Internal-Membrane Transporter Involved in Excretion of Amino Acids , 2004, Eukaryotic Cell.
[46] Miguel C. Teixeira,et al. Saccharomyces cerevisiae Multidrug Transporter Qdr2p (Yil121wp): Localization and Function as a Quinidine Resistance Determinant , 2004, Antimicrobial Agents and Chemotherapy.
[47] K. Barker,et al. Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. , 2003, The Journal of antimicrobial chemotherapy.
[48] Sandra Tenreiro,et al. Dtr1p, a Multidrug Resistance Transporter of the Major Facilitator Superfamily, Plays an Essential Role in Spore Wall Maturation in Saccharomyces cerevisiae , 2002, Eukaryotic Cell.
[49] T. Yamada-Okabe,et al. Characterization of the CaNAG3, CaNAG4, and CaNAG6 genes of the pathogenic fungus Candida albicans: possible involvement of these genes in the susceptibilities of cytotoxic agents. , 2002, FEMS microbiology letters.
[50] Miguel C. Teixeira,et al. AQR1 gene (ORF YNL065w) encodes a plasma membrane transporter of the major facilitator superfamily that confers resistance to short-chain monocarboxylic acids and quinidine in Saccharomyces cerevisiae. , 2002, Biochemical and biophysical research communications.
[51] S. Tenreiro,et al. Resistance and Adaptation to Quinidine in Saccharomyces cerevisiae: Role of QDR1 (YIL120w), Encoding a Plasma Membrane Transporter of the Major Facilitator Superfamily Required for Multidrug Resistance , 2001, Antimicrobial Agents and Chemotherapy.
[52] D. Sanglard,et al. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.
[53] A. Goffeau,et al. ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p* , 1998, The Journal of Biological Chemistry.
[54] M. Raymond,et al. AP1-mediated Multidrug Resistance in Saccharomyces cerevisiae Requires FLR1 Encoding a Transporter of the Major Facilitator Superfamily* , 1997, The Journal of Biological Chemistry.
[55] G. Fink,et al. HOL1 mutations confer novel ion transport in Saccharomyces cerevisiae. , 1990, Molecular and cellular biology.
[56] G. Ruiz,et al. What do we know about the biology of the emerging fungal pathogen of humans , 2020 .
[57]
A. Bharat,et al.
Tracing the Evolutionary History and Global Expansion of